Patent details

300767 Product Name: Combinatie van rilpivirine of een therapeutisch equivalente vorm daarvan die beschermd wordt door het basisoctrooi, zoals een farmaceutisch aanvaardbaar zout van rilpivirine, waaronder het hydrochloridezout van rilpivirine, en tenofovir, in het bijzonder tenofovirdisoproxilfumaraat.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300767
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1663240
Status:
Withdrawn
Application number:
300767
Procedural language:
Dutch
First Applicant Residence Country:
Ireland (IE)

Marketing Authorization

Marketing Authorization Number:
EU/1/11/737/001-002
Marketing Authorization Type:
EEA
Marketing Authorization Date:
28/11/2011
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
21/10/2015
First Marketing Authorization date:
28/11/2011
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/12/2015
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
14/09/2023
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
29/03/2023
 
 

 

Name:
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Address:
Barnahely Co Cork, Ringaskiddy, Ireland (IE)

Historical Applicant/holder

From:
29/03/2023
To:
29/03/2023

 

Name:
Janssen Sciences Ireland UC
Address:
Barnahely Co Cork, Ringaskiddy, Ireland (IE)

From:
21/10/2015
To:
29/03/2023

 

Name:
Janssen Sciences Ireland UC
Address:
Eastgate Village, Eastgate, LITTLE ISLAND, COUNTY CORK, Ireland (IE)

Agent

Name:
ir. F.A. Geurts c.s.
From:
10/12/2015
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
38/23
Publication date:
20/09/2023
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
15/23
Publication date:
12/04/2023
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
SPC
Journal edition number:
51/15
Publication date:
16/12/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC202300672A
Date Registered:
29/03/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC202300672B
Date Registered:
29/03/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
Address:
Barnahely Co Cork, Ringaskiddy, Ireland (IE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:
Filing date Document type Document Description Number of pages File Type
15/09/2023 Outgoing Correspondence Letter confirmation withdrawal 1 PDF /3/7/3/9/1/0800019373/docs/300767_13_566475l193.pdf
14/09/2023 SPC Documents Withdrawal SPC 1 PDF /3/7/3/9/1/0800019373/docs/300767_12_supplprotectioncertificate20230914043705092.pdf
09/08/2023 Outgoing Correspondence Letter to applicant 2 PDF /3/7/3/9/1/0800019373/docs/300767_11_560473l173.pdf
01/10/2021 Incoming Correspondence Paper Accompanying letter incoming document 4 PDF /3/7/3/9/1/0800019373/docs/300767_5_incomingcorrespondencepaper20211001125051566.pdf
01/07/2021 Outgoing Correspondence Letter to applicant 2 PDF /3/7/3/9/1/0800019373/docs/300767_3_419315l173.pdf
29/06/2017 Incoming Correspondence Paper Mail 2 PDF /3/7/3/9/1/0800019373/docs/300767_8_incomingcorrespondencepaper20200407083411208.pdf
02/02/2017 Outgoing Correspondence Letter to applicant 2 PDF /3/7/3/9/1/0800019373/docs/300767_10_outgoingcorrespondence20170203105444851.pdf
22/12/2015 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /3/7/3/9/1/0800019373/docs/300767_0_incomingcorrespondencepaper20151223122724039.pdf
11/12/2015 Outgoing Correspondence Outgoing Letter 1 PDF /3/7/3/9/1/0800019373/docs/300767_2_21565l174.pdf
21/10/2015 Application Form First filed application form 3 PDF /3/7/3/9/1/0800019373/docs/300767_1_applicationform20151210114840533.pdf
21/10/2015 SPC Documents Marketing Authorization SPC 4 PDF /3/7/3/9/1/0800019373/docs/300767_4_supplprotectioncertificate20200407084043053.pdf
21/10/2015 SPC Documents Annex SPC 1 PDF /3/7/3/9/1/0800019373/docs/300767_6_supplprotectioncertificate20200407084246556.pdf
21/10/2015 SPC Documents Accompanying letter SPC 1 PDF /3/7/3/9/1/0800019373/docs/300767_7_supplprotectioncertificate20210330024657362.pdf
21/10/2015 SPC Documents Summary of the characteristics of the product 33 PDF /3/7/3/9/1/0800019373/docs/300767_9_supplprotectioncertificate20200407083830379.pdf